JP Morgan Put 230 RMD 21.02.2025/ DE000JF1PTZ6 /
1/24/2025 9:37:13 AM | Chg.-0.100 | Bid10:00:34 PM | Ask10:00:34 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.520EUR | -16.13% | - Bid Size: - |
- Ask Size: - |
ResMed Inc | 230.00 USD | 2/21/2025 | Put |
GlobeNewswire
8/28/2024
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
GlobeNewswire
8/15/2024
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader ...
GlobeNewswire
7/25/2024
NATIONAL CENTER ON SHAKEN BABY SYNDROME AND XEALTH INCREASE SPEED AND ACCESSIBILITY OF CRITICAL PARE...
GlobeNewswire
6/27/2024
XEALTH LAUNCHES DEWEY, THE INDUSTRY’S FIRST PERFORMANCE-BASED, DIGITAL HEALTH BENCHMARKING TOOL
GlobeNewswire
6/10/2024
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep A...
GlobeNewswire
5/23/2024
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provid...
GlobeNewswire
5/16/2024
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and ...
GlobeNewswire
5/16/2024
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
5/7/2024
XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS
GlobeNewswire
4/10/2024
CHILDREN’S WISCONSIN REMOTELY MONITORING PEDIATRIC PATIENTS VIA XEALTH AND LOCUS HEALTH